RZOLV signs LOI with Alkemio Bioscience on rare earths, critical minerals recovery platform

• RZOLV signed a non-binding LOI dated July 15, 2026 with Alkemio Bioscience to pursue an integrated rare earths recovery platform.
• Collaboration targets modular processing from complex primary or secondary feedstocks through separated, higher-value rare earth products.
• RZOLV’s hydrometallurgical process would produce conditioned solutions; Alkemio’s molecular-recognition technology would handle separation, refining, upgrading.
• Parties aim to generate the technical and economic basis for pilot-scale validation, potential licensing, commercial deployment.
• Positive results could lead to a joint development deal, project pilots, an SPV, a commercial joint venture, or technology licensing agreements.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. RZOLV Technologies Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202607230830NEWSFILECNPR____20260723_306173_1) on July 23, 2026, and is solely responsible for the information contained therein.